PortfoliosLab logo
DXCM vs. TNDM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DXCM and TNDM is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

DXCM vs. TNDM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DexCom, Inc. (DXCM) and Tandem Diabetes Care, Inc. (TNDM). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

DXCM:

-0.60

TNDM:

-0.75

Sortino Ratio

DXCM:

-0.38

TNDM:

-0.76

Omega Ratio

DXCM:

0.93

TNDM:

0.89

Calmar Ratio

DXCM:

-0.51

TNDM:

-0.50

Martin Ratio

DXCM:

-0.82

TNDM:

-1.20

Ulcer Index

DXCM:

39.25%

TNDM:

39.63%

Daily Std Dev

DXCM:

58.58%

TNDM:

67.85%

Max Drawdown

DXCM:

-94.61%

TNDM:

-99.25%

Current Drawdown

DXCM:

-47.50%

TNDM:

-92.30%

Fundamentals

Market Cap

DXCM:

$33.52B

TNDM:

$1.54B

EPS

DXCM:

$1.33

TNDM:

-$2.79

PEG Ratio

DXCM:

1.32

TNDM:

0.00

PS Ratio

DXCM:

8.08

TNDM:

1.56

PB Ratio

DXCM:

14.82

TNDM:

9.90

Total Revenue (TTM)

DXCM:

$4.15B

TNDM:

$1.10B

Gross Profit (TTM)

DXCM:

$2.46B

TNDM:

$513.31M

EBITDA (TTM)

DXCM:

$889.80M

TNDM:

-$150.68M

Returns By Period

In the year-to-date period, DXCM achieves a 9.91% return, which is significantly higher than TNDM's -35.92% return. Over the past 10 years, DXCM has outperformed TNDM with an annualized return of 17.38%, while TNDM has yielded a comparatively lower -15.20% annualized return.


DXCM

YTD

9.91%

1M

24.66%

6M

12.65%

1Y

-34.93%

5Y*

-3.79%

10Y*

17.38%

TNDM

YTD

-35.92%

1M

36.89%

6M

-15.58%

1Y

-51.21%

5Y*

-22.89%

10Y*

-15.20%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DXCM vs. TNDM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DXCM
The Risk-Adjusted Performance Rank of DXCM is 2323
Overall Rank
The Sharpe Ratio Rank of DXCM is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of DXCM is 2525
Sortino Ratio Rank
The Omega Ratio Rank of DXCM is 2121
Omega Ratio Rank
The Calmar Ratio Rank of DXCM is 1818
Calmar Ratio Rank
The Martin Ratio Rank of DXCM is 3232
Martin Ratio Rank

TNDM
The Risk-Adjusted Performance Rank of TNDM is 1616
Overall Rank
The Sharpe Ratio Rank of TNDM is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of TNDM is 1616
Sortino Ratio Rank
The Omega Ratio Rank of TNDM is 1616
Omega Ratio Rank
The Calmar Ratio Rank of TNDM is 1818
Calmar Ratio Rank
The Martin Ratio Rank of TNDM is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DXCM vs. TNDM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Tandem Diabetes Care, Inc. (TNDM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current DXCM Sharpe Ratio is -0.60, which is comparable to the TNDM Sharpe Ratio of -0.75. The chart below compares the historical Sharpe Ratios of DXCM and TNDM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

DXCM vs. TNDM - Dividend Comparison

Neither DXCM nor TNDM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DXCM vs. TNDM - Drawdown Comparison

The maximum DXCM drawdown since its inception was -94.61%, roughly equal to the maximum TNDM drawdown of -99.25%. Use the drawdown chart below to compare losses from any high point for DXCM and TNDM. For additional features, visit the drawdowns tool.


Loading data...

Volatility

DXCM vs. TNDM - Volatility Comparison

The current volatility for DexCom, Inc. (DXCM) is 17.14%, while Tandem Diabetes Care, Inc. (TNDM) has a volatility of 21.19%. This indicates that DXCM experiences smaller price fluctuations and is considered to be less risky than TNDM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

DXCM vs. TNDM - Financials Comparison

This section allows you to compare key financial metrics between DexCom, Inc. and Tandem Diabetes Care, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B20212022202320242025
1.04B
234.42M
(DXCM) Total Revenue
(TNDM) Total Revenue
Values in USD except per share items

DXCM vs. TNDM - Profitability Comparison

The chart below illustrates the profitability comparison between DexCom, Inc. and Tandem Diabetes Care, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20212022202320242025
56.9%
50.5%
(DXCM) Gross Margin
(TNDM) Gross Margin
DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.

TNDM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tandem Diabetes Care, Inc. reported a gross profit of 118.41M and revenue of 234.42M. Therefore, the gross margin over that period was 50.5%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.

TNDM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tandem Diabetes Care, Inc. reported an operating income of -120.88M and revenue of 234.42M, resulting in an operating margin of -51.6%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.

TNDM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tandem Diabetes Care, Inc. reported a net income of -130.56M and revenue of 234.42M, resulting in a net margin of -55.7%.